Published in World J Gastroenterol on August 15, 2004
Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res Ther (2006) 1.06
Polylactide-cyclosporin A nanoparticles for targeted immunosuppression. FASEB J (2010) 0.94
Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches. Hum Immunol (2007) 0.83
Construction and evaluation of rats' tolerogenic dendritic cells (DC) induced by NF-κB Decoy method. Afr Health Sci (2014) 0.81
Dendritic cells and the control of immunity. Nature (1998) 56.54
Immunobiology of dendritic cells. Annu Rev Immunol (2000) 23.65
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med (2000) 6.45
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med (2001) 4.78
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med (1999) 3.17
Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med (1998) 2.66
Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity (2002) 2.31
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol (2000) 2.24
Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol (2001) 2.24
Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol (2002) 2.01
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation (1996) 1.86
Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol (1997) 1.81
Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol (2000) 1.77
Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation (1995) 1.63
Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells. Eur J Immunol (1991) 1.62
Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo. J Immunol (2000) 1.47
Monophosphoryl lipid A activates both human dendritic cells and T cells. J Immunol (2002) 1.36
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol (2002) 1.32
Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol (2001) 1.31
Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J Immunol (2001) 1.31
The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol (2001) 1.31
N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J Immunol (1999) 1.15
CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1. J Biol Chem (2002) 1.12
IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells. J Immunol (2001) 1.11
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther (2000) 1.10
Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. J Immunol (2000) 1.07
Retracted Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation (1999) 1.05
Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B. Transplantation (1999) 1.05
Estrogen increases sensitivity of hepatic Kupffer cells to endotoxin. Am J Physiol (1998) 1.03
A role for NF-kappaB-dependent gene transactivation in sunburn. J Clin Invest (2000) 1.01
Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness. Transplantation (1998) 1.01
Phenotype, function, and in vivo migration and survival of allogeneic dendritic cell progenitors genetically engineered to express TGF-beta. Transplantation (1998) 0.97
Il-12 antagonism enhances apoptotic death of T cells within hepatic allografts from Flt3 ligand-treated donors and promotes graft acceptance. J Immunol (2001) 0.96
Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection. Transplantation (2000) 0.92
Monocyte-derived dendritic cell precursors facilitate tolerance to heart allografts after total lymphoid irradiation. Transplantation (1998) 0.90
Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival. Transplantation (2002) 0.86
Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage. Transplantation (2002) 0.86
A pivotal role of Rho GTPase in the regulation of morphology and function of dendritic cells. J Immunol (2001) 0.86
Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors. Transplantation (2001) 0.85
Allograft tolerance induced by intact active bone co-transplantation and anti-CD40L monoclonal antibody therapy. Transplantation (2002) 0.85
Tolerance to rat liver allografts. I. Differences between tolerance and rejection are more marked in the B cell compared with the T cell or cytokine response. Transplantation (1994) 0.85
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation (1998) 0.83
Graft hyporeactivity induced by immature donor-derived dendritic cells. Transpl Immunol (2000) 0.83
Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides. Transplantation (1998) 0.82
Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow. Transplantation (1998) 0.81
Donor pretreatment with Flt-3 ligand augments antidonor cytotoxic T lymphocyte, natural killer, and lymphokine-activated killer cell activities within liver allografts and alters the pattern of intragraft apoptotic activity. Transplantation (1998) 0.81
Predominant expression of T helper 2 cytokines and altered expression of T helper 1 cytokines in long-term allograft survival induced by intrathymic immune modulation with donor class I major histocompatibility complex peptides. Transplantation (1998) 0.80
Differential effects of exogenous interleukin-10 on cardiac allograft survival: inhibition of rejection by recipient pretreatment reflects impaired host accessory cell function. Transplantation (1999) 0.79
Autocrine activation-induced cell death of T cells by human peripheral blood monocyte-derived CD4+ dendritic cells. Cell Immunol (2000) 0.77
Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res (2005) 2.34
Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci (2006) 2.07
Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int (2007) 1.56
Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K/Akt signaling pathways. Am J Physiol Heart Circ Physiol (2007) 1.55
Quantitative estimation of the degree of hepatic macrovesicular steatosis in a disease-free population: a single-center experience in mainland China. Liver Transpl (2009) 1.47
The first liver transplantation from infant donors after cardiac death in China. Pediatr Transplant (2012) 1.39
Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2015) 1.39
Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS One (2008) 1.26
NrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout mice. Neuropsychopharmacology (2006) 1.24
LPS induces HMGB1 relocation and release by activating the NF-κB-CBP signal transduction pathway in the murine macrophage-like cell line RAW264.7. J Surg Res (2011) 1.14
Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Ann N Y Acad Sci (2008) 1.12
Diagnosis and management of choledochoduodenal fistula. Am Surg (2011) 1.10
Health-related quality of life of 256 recipients after liver transplantation. World J Gastroenterol (2012) 1.07
Is absolute lymphocyte count a good prognostic predictor in recurrence of hepatocellular carcinoma after liver transplantation? Transplantation (2014) 1.07
Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. World J Gastroenterol (2013) 1.02
DNAzymes targeted to EBV-encoded latent membrane protein-1 induce apoptosis and enhance radiosensitivity in nasopharyngeal carcinoma. Cancer Lett (2008) 1.01
Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. J Surg Res (2008) 0.99
Analysis of infections in the first 3-month after living donor liver transplantation. World J Gastroenterol (2012) 0.99
Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients. World J Gastroenterol (2007) 0.94
Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma. Cancer Lett (2008) 0.93
Spontaneous hyaline cartilage regeneration can be induced in an osteochondral defect created in the femoral condyle using a novel double-network hydrogel. BMC Musculoskelet Disord (2011) 0.92
Lipopolysaccharide induced synthesis of CD14 proteins and its gene expression in hepatocytes during endotoxemia. World J Gastroenterol (2002) 0.92
Protective effect of glutamine-enriched early enteral nutrition on intestinal mucosal barrier injury after liver transplantation in rats. Am J Surg (2010) 0.92
Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Eur J Gastroenterol Hepatol (2013) 0.92
Treatment strategy for hepatic trauma. Chin J Traumatol (2016) 0.91
Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int (2010) 0.91
Role of high-intensity focused ultrasound in treatment of hepatocellular carcinoma. Am Surg (2011) 0.89
Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World J Gastroenterol (2012) 0.89
Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China. World J Gastroenterol (2003) 0.88
Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol (2009) 0.88
Interaction between AT1 receptor and NF-κB in hypothalamic paraventricular nucleus contributes to oxidative stress and sympathoexcitation by modulating neurotransmitters in heart failure. Cardiovasc Toxicol (2013) 0.88
Mirizzi syndrome: experience in diagnosis and treatment of 25 cases. Am Surg (2012) 0.88
Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87
Prevention of common bile duct injury during laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int (2009) 0.87
Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation. Hepatobiliary Pancreat Dis Int (2004) 0.87
Cell-targeting multifunctional nanospheres with both fluorescence and magnetism. Small (2005) 0.87
Improved two-cuff technique for orthotopic liver transplantation in rat. Hepatobiliary Pancreat Dis Int (2004) 0.87
Hemihepatic versus total hepatic inflow occlusion during hepatectomy: a systematic review and meta-analysis. World J Gastroenterol (2011) 0.86
Orthotopic liver transplantation for patients with Caroli's disease. Hepatobiliary Pancreat Dis Int (2008) 0.86
Joint immobilization inhibits spontaneous hyaline cartilage regeneration induced by a novel double-network gel implantation. J Mater Sci Mater Med (2010) 0.86
Expression and role of icam-1 in the occurrence and development of hepatocellular carcinoma. Asian Pac J Cancer Prev (2013) 0.86
Down-regulation of miRNA-452 is associated with adriamycin-resistance in breast cancer cells. Asian Pac J Cancer Prev (2014) 0.85
Renin-angiotensin system modulates neurotransmitters in the paraventricular nucleus and contributes to angiotensin II-induced hypertensive response. Cardiovasc Toxicol (2013) 0.85
Staging of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2003) 0.85
Pancreatic encephalopathy in 24 patients with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int (2004) 0.84
Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. World J Gastroenterol (2012) 0.84
Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Ann Hepatol (2012) 0.84
Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: a meta-analysis. World J Gastroenterol (2010) 0.84
Expression of toll-like receptor 4 and MD-2 gene and protein in Kupffer cells after ischemia-reperfusion in rat liver graft. World J Gastroenterol (2004) 0.84
Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2011) 0.84
Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol (2003) 0.84
Role of NF-kB in multiple organ dysfunction during acute obstructive cholangitis. World J Gastroenterol (2003) 0.83
Analysis of CD8+CD28- T-suppressor cells in living donor liver transplant recipients. Hepatobiliary Pancreat Dis Int (2009) 0.83
Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology (2012) 0.83
Diagnosis and cure experience of hepatolithiasis-associated intrahepatic cholangiocarcinoma in 66 patients. Asian Pac J Cancer Prev (2012) 0.83
Evaluation of standard liver volume formulae for Chinese adults. World J Gastroenterol (2009) 0.83
Caudate lobectomy by the third porta hepatis anatomical method: a study of 16 cases. Hepatobiliary Pancreat Dis Int (2006) 0.83
Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis. World J Gastroenterol (1999) 0.82
Graft size alone should not affect donors selection and be used to predict the prognosis of recipients after living donor liver transplantation. Hepatogastroenterology (2012) 0.82
Liver transplantation for patients with hepatolithiasis. Hepatobiliary Pancreat Dis Int (2005) 0.82
Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft. World J Gastroenterol (2004) 0.82
Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection. Asian J Surg (2004) 0.82
Prognostic value of hedgehog signal component expressions in hepatoblastoma patients. Eur J Med Res (2010) 0.82
A successful pregnancy following liver transplantation. Hepatobiliary Pancreat Dis Int (2007) 0.82
[Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma]. Ai Zheng (2007) 0.82
Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1. Chin Med J (Engl) (2007) 0.82
Delayed internal pancreatic fistula with pancreatic pleural effusion postsplenectomy. World J Gastroenterol (2010) 0.81
Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1--a multi-center and multi-biomarker study. Carcinogenesis (2007) 0.81
Treatment of hepatic venous outflow stenosis after living donor liver transplantation by insertion of an expandable metallic stent. Hepatobiliary Pancreat Dis Int (2009) 0.81
Safety of living donor liver transplantation using older donors. J Surg Res (2012) 0.81
Microsurgical reconstruction of hepatic artery in A-A LDLT: 124 consecutive cases without HAT. World J Gastroenterol (2010) 0.81
Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Hepatobiliary Pancreat Dis Int (2006) 0.81
Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. World J Gastroenterol (2012) 0.80
[Effect of starvation-induced autophagy on cell cycle of tumor cells]. Ai Zheng (2008) 0.80
Hepatic venous outflow reconstruction in right lobe graft without middle hepatic vein. Hepatol Res (2007) 0.80
Usage of 64-detector-row spiral computed tomography volumetry in preoperative volume prediction in living donor liver transplantation in children. Pediatr Surg Int (2011) 0.80
Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report. Hepatobiliary Pancreat Dis Int (2003) 0.80
Risks faced by donors of right lobe for living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2009) 0.80
Synthesis of endotoxin receptor CD14 protein in Kupffer cells and its role in alcohol-induced liver disease. World J Gastroenterol (2003) 0.80
Is correction for protein concentration appropriate for protein adduct dosimetry? Hypothesis and clues from an aflatoxin B1-exposed population. Cancer Sci (2007) 0.80
Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma. Hepatogastroenterology (2008) 0.80
Measures for increasing the safety of donors in living donor liver transplantation using right lobe grafts. Hepatobiliary Pancreat Dis Int (2007) 0.80
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol (2010) 0.80
Pancreaticoduodenectomy with early superior mesenteric artery dissection. Hepatobiliary Pancreat Dis Int (2010) 0.80
Problems in adult living donor liver transplantation using the right hepatic lobe. Hepatobiliary Pancreat Dis Int (2006) 0.79
Immunosuppressive effect of IDO on T cells in patients with chronic hepatitis B*. Hepatol Res (2008) 0.79
Retrospective analysis of prognostic factors after liver transplantation for intrahepatic cholangiocarcinoma in China: a single-center experience. Hepatogastroenterology (2011) 0.79
Relationship between growth hormone 1 genetic polymorphism and susceptibility to colorectal cancer. J Hum Genet (2010) 0.79
Donor safety and remnant liver volume in living donor liver transplantation. World J Gastroenterol (2012) 0.79
Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors. Hepatobiliary Pancreat Dis Int (2011) 0.79
Zinc finger protein A20 promotes regeneration of small-for-size liver allograft and suppresses rejection and results in a longer survival in recipient rats. J Surg Res (2008) 0.79
Association of PTPRB gene polymorphism with drug addiction. Am J Med Genet B Neuropsychiatr Genet (2008) 0.79
Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro. Hepatobiliary Pancreat Dis Int (2006) 0.79
Improved early diagnosis of cystadenocarcinoma of the pancreas. Hepatobiliary Pancreat Dis Int (2007) 0.79
Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy. World J Gastroenterol (2013) 0.79
[Paclitaxel induces apoptosis of acute leukemia cells in S phase]. Ai Zheng (2006) 0.79
Oncogenesis and the clinical significance of K-ras in pancreatic adenocarcinoma. Asian Pac J Cancer Prev (2013) 0.79